Follow
Gerrit Gmel
Gerrit Gmel
Clinical Research Manager, Saluda Medical; Research Methods Specialist, CAMH
Verified email at a3.epfl.ch
Title
Cited by
Cited by
Year
The relationship between different dimensions of alcohol use and the burden of disease—an update
J Rehm, GE Gmel Sr, G Gmel, OSM Hasan, S Imtiaz, S Popova, C Probst, ...
Addiction 112 (6), 968-1001, 2017
11182017
Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis
S Popova, S Lange, C Probst, G Gmel, J Rehm
The Lancet Global Health 5 (3), e290-e299, 2017
9852017
Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis
S Lange, C Probst, G Gmel, J Rehm, L Burd, S Popova
JAMA pediatrics 171 (10), 948-956, 2017
6222017
The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis
M Roerecke, J Kaczorowski, SW Tobe, G Gmel, OSM Hasan, J Rehm
The Lancet Public Health 2 (2), e108-e120, 2017
4902017
Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study
M Schütze, H Boeing, T Pischon, J Rehm, T Kehoe, G Gmel, A Olsen, ...
Bmj 342, 2011
4262011
Defining substance use disorders: do we really need more than heavy use?
J Rehm, S Marmet, P Anderson, A Gual, L Kraus, DJ Nutt, R Room, ...
Alcohol and alcoholism 48 (6), 633-640, 2013
2832013
Are the “best buys” for alcohol control still valid? An update on the comparative cost-effectiveness of alcohol control strategies at the global level
D Chisholm, D Moro, M Bertram, C Pretorius, G Gmel, K Shield, J Rehm
Journal of studies on alcohol and drugs 79 (4), 514-522, 2018
2642018
Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example
J Rehm, T Kehoe, G Gmel, F Stinson, B Grant, G Gmel
Population Health Metrics 8, 1-12, 2010
2482010
Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial
N Mekhail, RM Levy, TR Deer, L Kapural, S Li, K Amirdelfan, CW Hunter, ...
The Lancet Neurology 19 (2), 123-134, 2020
2222020
Burden of disease associated with alcohol use disorders in the United States
J Rehm, D Dawson, U Frick, G Gmel, M Roerecke, KD Shield, B Grant
Alcoholism: Clinical and Experimental Research 38 (4), 1068-1077, 2014
2022014
Global alcohol exposure estimates by country, territory and region for 2005—a contribution to the C omparative R isk A ssessment for the 2010 G lobal B urden of D isease S tudy
KD Shield, M Rylett, G Gmel, G Gmel, TAK Kehoe‐Chan, J Rehm
Addiction 108 (5), 912-922, 2013
1742013
Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms
T Kehoe, G Gmel, KD Shield, G Gmel, J Rehm
Population health metrics 10, 1-19, 2012
1722012
Global prevalence of alcohol use and binge drinking during pregnancy, and fetal alcohol spectrum disorder
S Popova, S Lange, C Probst, G Gmel, J Rehm
Biochemistry and Cell Biology 96 (2), 237-240, 2018
1202018
Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview
J Rehm, KD Shield, M Roerecke, G Gmel
BMC public health 16, 1-9, 2016
922016
Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption
KD Shield, G Gmel, J Patra, J Rehm
Population health metrics 10, 1-14, 2012
802012
Mortality and potential years of life lost attributable to alcohol consumption by race and sex in the United States in 2005
KD Shield, G Gmel, T Kehoe-Chan, DA Dawson, BF Grant, J Rehm
PLoS One 8 (1), e51923, 2013
782013
Life‐time risk of mortality due to different levels of alcohol consumption in seven European countries: implications for low‐risk drinking guidelines
KD Shield, G Gmel, G Gmel, P Mäkelä, C Probst, R Room, J Rehm
Addiction 112 (9), 1535-1544, 2017
772017
Monitoring brain neural potentials
JL Parker, GE Gmel
US Patent 11,172,864, 2021
762021
The Tangible Common Denominator of Substance Use Disorders: A Reply to Commentaries to Rehm et al. (2013a)
J Rehm, P Anderson, A Gual, L Kraus, S Marmet, DJ Nutt, R Room, ...
Alcohol and alcoholism 49 (1), 118-122, 2014
692014
Estimating the harms and costs of cannabis-attributable collisions in the Canadian provinces
A Wettlaufer, RO Florica, M Asbridge, D Beirness, J Brubacher, ...
Drug and Alcohol Dependence 173, 185-190, 2017
662017
The system can't perform the operation now. Try again later.
Articles 1–20